Effect of different doses of borneol on the pharmacokinetics of vinpocetine in rat plasma and brain after intraocular administration

References

• Barar J, Asadi M, Mortazavi-Tabatabaei SA, Omidi Y. (2009). Ocular drug delivery; impact of in vitro cell culture models. J Ophthalmic Vis Res 4:238–52.
   PubMedGoogle Scholar
• Bereczki D, Fekete I. (1999). A systematic review of vinpocetine therapy in acute ischaemic stroke. Eur J Clin Pharmacol 55:349–52.
   PubMed Web of Science ®Google Scholar
• Cai Z, Hou S, Li Y, et al. (2008). Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration. J Drug Target 16:178–84.
   PubMed Web of Science ®Google Scholar
• Cai Z, Lei X, Lin Z, et al. (2014). Preparation and evaluation of sustained-release solid dispersions co-loading gastrodin with borneol as an oral brain-targeting enhancer. Acta Pharm Sin B 4:86–93.
   PubMed Web of Science ®Google Scholar
• Chen J, Cai J, Tao W, et al. (2006). Determination of apovincaminic acid in human plasma by high-performance liquid chromatography using solid-phase extraction and ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci 830:201–6.
   PubMed Web of Science ®Google Scholar
• Chiou GC. (1994). Systemic delivery of polypeptide drugs through ocular route. J Ocul Pharmacol Ther 10:93–9.
   Google Scholar
• Chiou GC, Chuang CY. (1989). Improvement of systemic absorption of insulin through eyes with absorption enhancers. J Pharm Sci 78:815–8.
   PubMed Web of Science ®Google Scholar
• Dhuria SV, Hanson LR, Frey WH. (2010). Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99:1654–60.
   PubMed Web of Science ®Google Scholar
• Ding J, Sun Y, Li J, et al. (2017). Enhanced blood–brain barrier transport of vinpocetine by oral delivery of mixed micelles in combination with a message guider. J Drug Target 25:532–40.
   PubMed Web of Science ®Google Scholar
• Gao C, Li X, Li Y, et al. (2010). Pharmacokinetic interaction between puerarin and edaravone, and effect of borneol on the brain distribution kinetics of puerarin in rats. J Pharm Pharmacol 62:360–7.
   PubMed Web of Science ®Google Scholar
• Gaudana R, Jwala J, Boddu SHS, Mitra AK. (2009). Recent perspectives in ocular drug delivery. Pharm Res 26:1197–216.
   PubMed Web of Science ®Google Scholar
• Grandt R, Beitinger H, Schaltenbrand R, Braun W. (1989). Vinpocetine pharmacokinetics in elderly subjects. Arzneimittelforschung 39:1599–602.
   PubMed Web of Science ®Google Scholar
• Hammes W, Weyhenmeyer R. (1987). Quantitative determination of vinpocetine in human plasma by capillary gas chromatography–mass spectrometry. J Chromatogr A 413:264–9.
   Web of Science ®Google Scholar
• Hammes W, Weyhenmeyer R. (1991). New assay method for the determination of vinpocetine in human plasma by gas chromatography-mass spectrometry without transesterification caused by solvents: a reply. J Chromatogr 567:504–5.
   PubMedGoogle Scholar
• He Z, Liu Z, Tian H, et al. (2018). Scalable production of core-shell nanoparticles by flash nanocomplexation to enhance mucosal transport for oral delivery of insulin. Nanoscale 10:3307–19.
   PubMed Web of Science ®Google Scholar
• Kraus G, Schulz HU, Lohmann A. (1992). Determination of apovincaminic acid in serum by means of high-performance liquid chromatography. J Chromatogr A 573:323–7.
   Web of Science ®Google Scholar
• Laksitorini M, Prasasty VD, Kiptoo PK, Siahaan TJ. (2014). Pathways and progress in improving drug delivery through the intestinal mucosa and blood–brain barriers. Ther Deliv 5:1143–63.
   PubMedGoogle Scholar
• Li, F, Mao, D, Dai, M M, et al. (2019). Pharmacokinetics of Nimodipine after Intraocular Administration in Rats. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 41:57–62.
   PubMedGoogle Scholar
• Lin C, Chen F, Ye T, et al. (2014). A novel oral delivery system consisting in “drug-in cyclodextrin-in nanostructured lipid carriers” for poorly water-soluble drug: vinpocetine. Int J Pharm 465:90–6.
   PubMed Web of Science ®Google Scholar
• Lu, Y, Du, S-y, Chen, X-l, et al. (2011). Enhancing effect of natural borneol on the absorption of geniposide in rat via intranasal administration. J Zhejiang Univ Sci B 12:143–8. 
   Google Scholar
• Lu Y, Du S, Bai J, et al. (2012). Bioavailability and brain-targeting of geniposide in gardenia-borneol co-compound by different administration routes in mice. Int J Mol Sci 13:14127–35.
   PubMed Web of Science ®Google Scholar
• Mannermaa E, Vellonen KS, Urtti A. (2006). Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 58:1136–63.
   PubMed Web of Science ®Google Scholar
• Maya MT, Pais JP, Araújo HM, Morais JA. (1996). Determination of apovincaminic acid in human plasma by high-performance liquid chromatography. J Pharm Biomed Anal 14:617–22.
   PubMed Web of Science ®Google Scholar
• Mei CX, Bi ZJ, Dong SW, Jian ZL. (2006). Effect of absorption enhancer of borneol on ginsenoside rg1 and the nasal ciliotoxicity. Chin Pharm J 41:261–4.
   Google Scholar
• Miller JW, Balyan R, Dong M, et al. (2018). Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study. Br J Anaesth 120:1056–65.
   PubMed Web of Science ®Google Scholar
• Newton C, Gebhardt BM, Kaufman HE. (1988). Topically applied cyclosporine in Azone prolongs corneal allograft survival. Invest Ophthalmol Vis Sci 29:208–15.
   PubMed Web of Science ®Google Scholar
• Tang HT, Li LX, Zhang J, et al. (2005). Current advance on study of increasing blood-brain barrier permeability by boneol. Chin J Neuro-Oncol 3:124–7.
   Google Scholar
• Vatsova M, Tzvetanov S, Drenska A, et al. (1997). Improved gas chromatographic–mass spectrometric method for the quantitative determination of vinpocetine in human plasma. J Chromatogr B Biomed Sci Appl 702:221–6.
   PubMedGoogle Scholar
• Vlase L, Imre S, Leucuta S. (2006). New HPLC–MS method for quantitative determination of apovincaminic acid in human plasma. J Sep Sci 29:385–9.
   PubMed Web of Science ®Google Scholar
• Wang LP, Feng JF, Hu KL. (2014). Progress in regulation effect of aromatic refreshing traditional Chinese medicine on BBB permeability and its mechanism. Zhongguo Zhong Yao Za Zhi 39:949–54.
   PubMedGoogle Scholar
• Xia HM, Su LN, Guo JW, et al. (2010). Determination of vinpocetine and its primary metabolite, apovincaminic acid, in rat plasma by liquid chromatography–tandem mass spectrometry. J Chromatogr B 878:1959–66.
   PubMedGoogle Scholar
• Xiao S, Yang L, Ran W, et al. (2012). In situ and in vivo study of nasal absorption of borneol in rats. Pharmazie 67:848–51.
   PubMed Web of Science ®Google Scholar
• Xiong Z-Y, Xiao F-M, Xu X, et al. (2013). Studies on pharmacological activity of borneol. Zhongguo Zhong Yao Za Zhi 38:786–90.
   PubMedGoogle Scholar
• Yan YX, Qi NP, Zhi PC. (2007). The enhancing effect of synthetical borneol on the absorption of tetramethylpyrazine phosphate in mouse. Int J Pharm 337:74–9.
   PubMedGoogle Scholar
• Yellepeddi VK, Palakurthi S. (2016). Recent advances in topical ocular drug delivery. J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther 32:67.
   PubMed Web of Science ®Google Scholar
• Yi T, Tang D, Wang F, et al. (2017). Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies. Drug Deliv 24:422–9.
   PubMed Web of Science ®Google Scholar
• Yu B, Ruan M, Cui X, et al. (2013). Effects of borneol on the pharmacokinetics of geniposide in cortex, hippocampus, hypothalamus and striatum of conscious rat by simultaneous brain microdialysis coupled with UPLC–MS. J Pharm Biomed Anal 77:128–32.
   PubMed Web of Science ®Google Scholar
• Zhuang CY, Li N, Wang M, et al. (2010). Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (nlc) for improved oral bioavailability. Int J Pharm 394:179–85.
   PubMed Web of Science ®Google Scholar
• Zhao JY, Lu Y, Du SY, et al. (2012). Comparative pharmacokinetic studies of borneol in mouse plasma and brain by different administrations. J Zhejiang Univ Sci B 13:990–6.
   PubMed Web of Science ®Google Scholar
• Zhao BS, Dong SY, Mi SQ. (2002). The influence of borneol to the iNOS of brain microvascular endothelial cells. Chin Pharmacol Bull 18:590–1.
   Google Scholar
• Zhang Y, Zhang N, Song H, et al. (2019). Design, characterization and comparison of transdermal delivery of colchicine via borneol-chemically-modified and borneol-physically-modified ethosome. Drug Deliv 6:70–7.
   Google Scholar
• Zhang Q, Wu D, Wu J, et al. (2015). Improved blood–brain barrier distribution: effect of borneol on the brain pharmacokinetics of kaempferol in rats by in vivo microdialysis sampling. J Ethnopharmacol 162:270–7.
   PubMed Web of Science ®Google Scholar
• Zhang QL, Fu BM, Zhang ZJ. (2017). Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood–brain barrier permeability. Drug Deliv 24:1037–44.
   PubMed Web of Science ®Google Scholar